Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?

Michael C. Cheung, Relin Yang, Margaret M. Byrne, Carmen C. Solorzano, Attila Nakeeb, Leonidas G. Koniaris

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

BACKGROUND: The objective of this study was to define the effects of socioeconomic status (SES) and other demographic variables on outcomes for patients with pancreatic adenocarcinoma. METHODS: Florida cancer registry and inpatient hospital data were queried for pancreatic adenocarcinoma diagnosed from 1998 to 2002. RESULTS: In total, 16,104 patients were identified. Low SES (LSES) patients were younger at diagnosis (P < .001) but presented with similar disease stage and tumor grade. LSES patients were less likely to receive surgical extirpation (16.5% vs 19.8%; P < .001), chemotherapy (30.7% vs 36.4%; P < .001), or radiotherapy (14.3% vs 16.9%; P=.003). Among surgical patients, 30-day mortality was significantly higher (5.1% vs 3.7%; P < .001) and overall median survival was significantly worse (5.0 months vs 6.2 months; P < .001) in the LSES cohorts. Although surgical patients who were treated at teaching facilities (TF) did significantly better; an increased 30-day surgical mortality (2.2% vs 1.3%; P < .001) and decreased median survival (5 months for poverty level >15% vs 6.2 months for poverty level <5%; P < .001) also were observed for patients of LSES. In a multivariate analysis that corrected for patient comorbidities, significant independent predictors of a poorer prognosis included LSES (hazard ratio [HR], 1.09); treatment at a non-TF (HR, 1.09); and failure to receive surgical extirpation (HR, 1.92), chemotherapy (HR 1.41), or radiation (HR 1.25). CONCLUSIONS: Patients of LSES were less likely to receive surgical extirpation, chemotherapy, or radiation and had significantly higher perioperative and long-term mortality rates. A greater understanding of the barriers to providing optimal care and identifying means for improving successful delivery of therapies to the poor with pancreatic cancer are needed.

Original languageEnglish (US)
Pages (from-to)723-733
Number of pages11
JournalCancer
Volume116
Issue number3
DOIs
StatePublished - Feb 1 2010

Fingerprint

Social Class
Adenocarcinoma
Radiation
Drug Therapy
Poverty
Pancreatic Neoplasms
Registries
Comorbidity
Inpatients
Multivariate Analysis
Demography
Mortality
Therapeutics
Neoplasms

Keywords

  • Outcomes
  • Pancreatic cancer
  • Racial disparities
  • Socioeconomic status

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma? / Cheung, Michael C.; Yang, Relin; Byrne, Margaret M.; Solorzano, Carmen C.; Nakeeb, Attila; Koniaris, Leonidas G.

In: Cancer, Vol. 116, No. 3, 01.02.2010, p. 723-733.

Research output: Contribution to journalArticle

Cheung, Michael C. ; Yang, Relin ; Byrne, Margaret M. ; Solorzano, Carmen C. ; Nakeeb, Attila ; Koniaris, Leonidas G. / Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?. In: Cancer. 2010 ; Vol. 116, No. 3. pp. 723-733.
@article{010db26f82b04d7f88208eca06f8ee2c,
title = "Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?",
abstract = "BACKGROUND: The objective of this study was to define the effects of socioeconomic status (SES) and other demographic variables on outcomes for patients with pancreatic adenocarcinoma. METHODS: Florida cancer registry and inpatient hospital data were queried for pancreatic adenocarcinoma diagnosed from 1998 to 2002. RESULTS: In total, 16,104 patients were identified. Low SES (LSES) patients were younger at diagnosis (P < .001) but presented with similar disease stage and tumor grade. LSES patients were less likely to receive surgical extirpation (16.5{\%} vs 19.8{\%}; P < .001), chemotherapy (30.7{\%} vs 36.4{\%}; P < .001), or radiotherapy (14.3{\%} vs 16.9{\%}; P=.003). Among surgical patients, 30-day mortality was significantly higher (5.1{\%} vs 3.7{\%}; P < .001) and overall median survival was significantly worse (5.0 months vs 6.2 months; P < .001) in the LSES cohorts. Although surgical patients who were treated at teaching facilities (TF) did significantly better; an increased 30-day surgical mortality (2.2{\%} vs 1.3{\%}; P < .001) and decreased median survival (5 months for poverty level >15{\%} vs 6.2 months for poverty level <5{\%}; P < .001) also were observed for patients of LSES. In a multivariate analysis that corrected for patient comorbidities, significant independent predictors of a poorer prognosis included LSES (hazard ratio [HR], 1.09); treatment at a non-TF (HR, 1.09); and failure to receive surgical extirpation (HR, 1.92), chemotherapy (HR 1.41), or radiation (HR 1.25). CONCLUSIONS: Patients of LSES were less likely to receive surgical extirpation, chemotherapy, or radiation and had significantly higher perioperative and long-term mortality rates. A greater understanding of the barriers to providing optimal care and identifying means for improving successful delivery of therapies to the poor with pancreatic cancer are needed.",
keywords = "Outcomes, Pancreatic cancer, Racial disparities, Socioeconomic status",
author = "Cheung, {Michael C.} and Relin Yang and Byrne, {Margaret M.} and Solorzano, {Carmen C.} and Attila Nakeeb and Koniaris, {Leonidas G.}",
year = "2010",
month = "2",
day = "1",
doi = "10.1002/cncr.24758",
language = "English (US)",
volume = "116",
pages = "723--733",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?

AU - Cheung, Michael C.

AU - Yang, Relin

AU - Byrne, Margaret M.

AU - Solorzano, Carmen C.

AU - Nakeeb, Attila

AU - Koniaris, Leonidas G.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - BACKGROUND: The objective of this study was to define the effects of socioeconomic status (SES) and other demographic variables on outcomes for patients with pancreatic adenocarcinoma. METHODS: Florida cancer registry and inpatient hospital data were queried for pancreatic adenocarcinoma diagnosed from 1998 to 2002. RESULTS: In total, 16,104 patients were identified. Low SES (LSES) patients were younger at diagnosis (P < .001) but presented with similar disease stage and tumor grade. LSES patients were less likely to receive surgical extirpation (16.5% vs 19.8%; P < .001), chemotherapy (30.7% vs 36.4%; P < .001), or radiotherapy (14.3% vs 16.9%; P=.003). Among surgical patients, 30-day mortality was significantly higher (5.1% vs 3.7%; P < .001) and overall median survival was significantly worse (5.0 months vs 6.2 months; P < .001) in the LSES cohorts. Although surgical patients who were treated at teaching facilities (TF) did significantly better; an increased 30-day surgical mortality (2.2% vs 1.3%; P < .001) and decreased median survival (5 months for poverty level >15% vs 6.2 months for poverty level <5%; P < .001) also were observed for patients of LSES. In a multivariate analysis that corrected for patient comorbidities, significant independent predictors of a poorer prognosis included LSES (hazard ratio [HR], 1.09); treatment at a non-TF (HR, 1.09); and failure to receive surgical extirpation (HR, 1.92), chemotherapy (HR 1.41), or radiation (HR 1.25). CONCLUSIONS: Patients of LSES were less likely to receive surgical extirpation, chemotherapy, or radiation and had significantly higher perioperative and long-term mortality rates. A greater understanding of the barriers to providing optimal care and identifying means for improving successful delivery of therapies to the poor with pancreatic cancer are needed.

AB - BACKGROUND: The objective of this study was to define the effects of socioeconomic status (SES) and other demographic variables on outcomes for patients with pancreatic adenocarcinoma. METHODS: Florida cancer registry and inpatient hospital data were queried for pancreatic adenocarcinoma diagnosed from 1998 to 2002. RESULTS: In total, 16,104 patients were identified. Low SES (LSES) patients were younger at diagnosis (P < .001) but presented with similar disease stage and tumor grade. LSES patients were less likely to receive surgical extirpation (16.5% vs 19.8%; P < .001), chemotherapy (30.7% vs 36.4%; P < .001), or radiotherapy (14.3% vs 16.9%; P=.003). Among surgical patients, 30-day mortality was significantly higher (5.1% vs 3.7%; P < .001) and overall median survival was significantly worse (5.0 months vs 6.2 months; P < .001) in the LSES cohorts. Although surgical patients who were treated at teaching facilities (TF) did significantly better; an increased 30-day surgical mortality (2.2% vs 1.3%; P < .001) and decreased median survival (5 months for poverty level >15% vs 6.2 months for poverty level <5%; P < .001) also were observed for patients of LSES. In a multivariate analysis that corrected for patient comorbidities, significant independent predictors of a poorer prognosis included LSES (hazard ratio [HR], 1.09); treatment at a non-TF (HR, 1.09); and failure to receive surgical extirpation (HR, 1.92), chemotherapy (HR 1.41), or radiation (HR 1.25). CONCLUSIONS: Patients of LSES were less likely to receive surgical extirpation, chemotherapy, or radiation and had significantly higher perioperative and long-term mortality rates. A greater understanding of the barriers to providing optimal care and identifying means for improving successful delivery of therapies to the poor with pancreatic cancer are needed.

KW - Outcomes

KW - Pancreatic cancer

KW - Racial disparities

KW - Socioeconomic status

UR - http://www.scopus.com/inward/record.url?scp=76249103882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76249103882&partnerID=8YFLogxK

U2 - 10.1002/cncr.24758

DO - 10.1002/cncr.24758

M3 - Article

C2 - 19998350

AN - SCOPUS:76249103882

VL - 116

SP - 723

EP - 733

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -